Haematologic Technologies, Inc. (HTI) is a primary manufacturer specialising in the isolation and characterisation of plasma proteins involved in the coagulation cascade and bone metabolism regulation for in vitro research use.
The portfolio includes:
- Over 150 highly purified and well-characterised proteins, including zymogens, enzymes, co-factors and inhibitors, as well as a complementary line of monoclonal and polyclonal antibodies
- An extensive line of proteins from human, bovine and murine source plasma including the coagulation factors as well as inhibitors, platelet and bone proteins
- Factor-deficient plasmas
- Customised, blood collection tubes made-to-order for clinical research
Cambridge Bioscience is pleased to be the exclusive distributor for Haematologic Technologies, Inc. in the UK and Ireland.